Bristol Myers Squibb Other Non-Current Liabilities 2010-2024 | BMY

Bristol Myers Squibb other non-current liabilities for the quarter ending September 30, 2024 were $4.728B, a 23.78% decline year-over-year.

  • Bristol Myers Squibb other non-current liabilities for 2023 were $6.421B, a 2.56% decline from 2022.
  • Bristol Myers Squibb other non-current liabilities for 2022 were $6.59B, a 10.14% decline from 2021.
  • Bristol Myers Squibb other non-current liabilities for 2021 were $7.334B, a 5.68% decline from 2020.

Bristol Myers Squibb Other Non-Current Liabilities 2010-2024 | BMY

  • Bristol Myers Squibb other non-current liabilities for 2023 were $6.421B, a 2.56% decline from 2022.
  • Bristol Myers Squibb other non-current liabilities for 2022 were $6.59B, a 10.14% decline from 2021.
  • Bristol Myers Squibb other non-current liabilities for 2021 were $7.334B, a 5.68% decline from 2020.